Detailed phenotype of RNF213 p.R4810K variant identified by the Chinese patients with acute ischaemic stroke or transient ischaemic attack

Background and purpose The ring finger protein 213 gene (RNF213) p.R4810K variant increased the risk of acute ischaemic stroke (AIS) attributable to intracranial arterial stenosis (ICAS) in the Japanese and Korean populations. In this study, we aimed to examine the prevalence of the RNF213 p.R4810K variant in Chinese patients with AIS or transient ischaemic attack and identify the phenotype of the carriers. Methods We analysed data from the Third China National Stroke Registry. All included participants were divided into two groups by carrier status of the p.R4810K variant. The aetiological classification was conducted according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. The presence of ICAS and extracranial arterial stenosis (ECAS) was defined as 50%–99% stenosis or occlusion of any intracranial and extracranial artery. Logistic regression models and Cox regression models were used to evaluate the association of the p.R4810K variant with TOAST classification, stenosis phenotypes and clinical outcomes. Results A total of 10 381 patients were enrolled, among which 56 (0.5%) had the heterozygote GA genotype for p.R4810K. The variant carriers were younger (p=0.01), and more likely to suffer from peripheral vascular disease (p=0.04). The p.R4810K variant was associated with large-artery atherosclerosis (LAA) (adjusted OR=1.94, 95% CI 1.13 to 3.33), anterior circulation stenosis (adjusted OR=2.12, 95% CI 1.23 to 3.65) and ECAS (adjusted OR=2.29, 95% CI 1.16 to 4.51). Nevertheless, the p.R4810K variant was not associated with recurrence, poor functional outcome and mortality at 3 months and 1 year. Conclusions The RNF213 p.R4810K variant was associated with LAA, anterior circulation stenosis and ECAS in Chinese patients. Given the low carrying rate and only 1-year follow-up information, caution should be taken to interpret our findings in no statistically significant association between the p.R4810K variant and stroke prognosis in Chinese patients.

[1]  G. Steinberg,et al.  Moyamoya disease: diagnosis and interventions , 2022, The Lancet Neurology.

[2]  K. Nishimura,et al.  Association of the RNF213 p.R4810K Variant With the Outer Diameter of Cervical Arteries in Patients With Ischemic Stroke , 2022, Stroke: Vascular and Interventional Neurology.

[3]  E. Huang,et al.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. , 2021, Diabetes care.

[4]  P. Whelton,et al.  Guideline-Driven Management of Hypertension , 2021, Circulation research.

[5]  Jinkwon Kim,et al.  Association of genetic variants of RNF213 with ischemic stroke risk in Koreans , 2021, Genes & Genomics.

[6]  Wanyang Liu,et al.  Association of Genetic Variants With Moyamoya Disease in 13 000 Individuals , 2020, Stroke.

[7]  N. Saito,et al.  Hemorrhagic onset intracranial artery dissection of middle cerebral artery followed by progressive arterial stenosis with genetic variant RNF213 p.Arg4810Lys (rs112735431). , 2020, World neurosurgery.

[8]  Hao Li,et al.  Gene panel for Mendelian strokes , 2020, Stroke and vascular neurology.

[9]  J. Zeng,et al.  Mutations of RNF213 are responsible for sporadic cerebral cavernous malformation and lead to a mulberry-like cluster in zebrafish , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  T. Maehara,et al.  De Novo Renal Artery Stenosis Developed in Initially Normal Renal Arteries during the Long-Term Follow-Up of Patients with Moyamoya Disease. , 2020, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[11]  Yufang Wang,et al.  Prevalence of RNF213 variants in symptomatic intracranial arterial stenosis/occlusion in China , 2020, Molecular Genetics and Genomics.

[12]  Qian Zhang,et al.  Predictive role of heterozygous p.R4810K of RNF213 in the phenotype of Chinese moyamoya disease , 2020, Neurology.

[13]  T. Kawamata,et al.  Can Moyamoya Disease Susceptibility Gene Affect Extracranial Systemic Artery Stenosis? , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[14]  Seung-Chyul Hong,et al.  Moyamoya Disease and Spectrums of RNF213 Vasculopathy , 2019, Translational Stroke Research.

[15]  Zixiao Li,et al.  The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics , 2019, Stroke and Vascular Neurology.

[16]  H. Maruyama,et al.  Prevalence of RNF213 p.R4810K Variant in Early-Onset Stroke With Intracranial Arterial Stenosis. , 2019, Stroke.

[17]  Haiqing Song,et al.  The Clinical and Vascular Characteristics of RNF213 c.14576G>A Variant-Related Intracranial Major Artery Disease in China , 2019, Behavioural neurology.

[18]  Y. Kamatani,et al.  Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis. , 2019, Circulation.

[19]  Seung-Chyul Hong,et al.  Cav-1 (Caveolin-1) and Arterial Remodeling in Adult Moyamoya Disease , 2018, Stroke.

[20]  Y. Liu,et al.  Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report , 2018, Clinical Neurology and Neurosurgery.

[21]  J. Arenillas,et al.  Intracranial Large Artery Disease of Non-Atherosclerotic Origin: Recent Progress and Clinical Implications , 2018, Journal of stroke.

[22]  W. Dai,et al.  Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review , 2017, Environmental Health and Preventive Medicine.

[23]  Jin-Hong Shin,et al.  RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans , 2017, Journal of the Neurological Sciences.

[24]  B. Kim,et al.  Nonatheroscleotic Isolated Middle Cerebral Artery Disease May Be Early Manifestation of Moyamoya Disease , 2016, Stroke.

[25]  Seung-Chyul Hong,et al.  A Polymorphism in RNF213 Is a Susceptibility Gene for Intracranial Atherosclerosis , 2016, PloS one.

[26]  D. Taura,et al.  Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo , 2015, Journal of the American Heart Association.

[27]  Yilong Wang,et al.  Totaled Health Risks in Vascular Events Score Predicts Clinical Outcome and Symptomatic Intracranial Hemorrhage in Chinese Patients After Thrombolysis , 2015, Stroke.

[28]  T. Tominaga,et al.  Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene , 2014, Neuroreport.

[29]  Gao T. Wang,et al.  RNF213 Rare Variants in an Ethnically Diverse Population With Moyamoya Disease , 2014, Stroke.

[30]  Qiang Li,et al.  Serum miRNA Signature in Moyamoya Disease , 2014, PloS one.

[31]  Elsa Azevedo,et al.  Intracranial arterial stenosis. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[32]  A. Mukasa,et al.  Genetic Variant RNF213 c.14576G>A in Various Phenotypes of Intracranial Major Artery Stenosis/Occlusion , 2013, Stroke.

[33]  A. Mukasa,et al.  Identification of a Genetic Variant Common to Moyamoya Disease and Intracranial Major Artery Stenosis/Occlusion , 2012, Stroke.

[34]  A. Fujiyama,et al.  Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development , 2011, PloS one.

[35]  H. A. Smith,et al.  A standardized method for measuring intracranial arterial stenosis. , 2000, AJNR. American journal of neuroradiology.

[36]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[37]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[38]  T. Tominaga,et al.  De Novo Development of Moyamoya Disease in an Adult Female with a Genetic Variant of the RNF-213 Gene: Case Report. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[39]  A. Yamamoto,et al.  Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). , 2012, Neurologia medico-chirurgica.

[40]  Sean I. Savitz,et al.  Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis , 2012 .

[41]  A. Hata,et al.  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene , 2011, Journal of Human Genetics.

[42]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .